NextPlat (NXPL) Total Debt (2011 - 2026)
NextPlat's (NXPL) quarterly Total Debt came in at $1.2 million in Q2 2026, down 12.86% year-over-year from $1.4 million in Q2 2025, and down 18.06% quarter-over-quarter from $1.5 million in Q1 2026.
Analysis
NextPlat (NXPL) Total Debt (2011 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Total Debt for 16 consecutive years, with $1.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Debt fell 12.86% year-over-year to $1.2 million in Q2 2026; TTM through Jun 2026 was $1.2 million, a 12.86% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 4.69% from the prior year.
- Total Debt was $1.2 million for Q2 2026 at NextPlat, down from $1.5 million in the prior quarter.
- Over five years, Total Debt peaked at $2.0 million in Q3 2023 and troughed at $194778.0 in Q2 2023.
- A 5-year average of $1.2 million and a median of $1.4 million in 2025 frame the typical range for Total Debt.
- Across the five-year window, Total Debt plunged 51.4% in 2022 and surged 846.04% in 2023, its largest moves.
- Over 5 years, Total Debt stood at $276000.0 in 2022, then soared by 564.86% to $1.8 million in 2023, then slipped by 2.34% to $1.8 million in 2024, then retreated by 4.69% to $1.7 million in 2025, then slumped by 30.15% to $1.2 million in 2026.
- The last three Total Debt figures came in at $1.2 million (Q2 2026), $1.5 million (Q1 2026), and $1.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 16.59 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 13.35 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 813.33 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 2.67 Bn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 21.61 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 301.48 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 1.34 Bn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 612.05 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 1.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.19 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | 1.41 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 1.79 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 1.63 Mn |
| Dec 31, 2023 | 1.84 Mn |
| Sep 30, 2023 | 2.02 Mn |
| Jun 30, 2023 | 194,778.00 |
| Mar 31, 2023 | 206,133.00 |
| Dec 31, 2022 | 276,000.00 |
| Sep 30, 2022 | 213,708.00 |
| Jun 30, 2022 | 248,369.00 |
| Mar 31, 2022 | 274,012.00 |
| Dec 31, 2021 | 310,148.00 |
| Sep 30, 2021 | 335,801.00 |